Stockato

ALAB Due Diligence — Astera Labs, Inc.

Sam's full due-diligence report on ALAB (Astera Labs, Inc.) — verdict, conviction score, key metrics, and the signal behind it.

Hold5/10Bearish consensusPrice: $380.48P/E: 262.97Market cap: $66.7BRevenue (TTM): $1.0BProfit margin: 27%

$ALAB Due Diligence — Astera Labs, Inc.

Hold · 5/10 · Bearish consensus — full report on Stockato.

Price: $380.48
P/E: 262.97
Market cap: $66.7B
Revenue (TTM): $1.0B
Profit margin: 27%

VERDICT: HOLD
SCORE: 5/10
CONFIDENCE: MEDIUM — based on signal agreement

COMPANY OVERVIEW
Astera Labs designs semiconductor connectivity solutions (PCIe/CXL retimers, Scorpio switches) for AI/cloud infrastructure. It reported $1.00B TTM revenue with 93% YoY growth, serving hyperscalers via high-speed data fabric products.

KEY FUNDAMENTALS
Revenue TTM $1.00B (+93% YoY), gross margin ~76%, operating margin 20.1%, P/S 66.6x, forward P/E 131.6x. Consensus: 18 Buy/Strong Buy, 8 Hold, 0 Sell; average target $245 vs current $380. Short interest 9.15% of float, down 9.3% MoM.

BULL CASE
- Nasdaq-100 inclusion (announced June 12, effective June 22) triggers mandatory QQQ/passive buying.
- Q1 revenue +93% YoY; non-GAAP op. margins expanded to >40% over eight quarters.
- NVLink Fusion partnership with NVIDIA positions ALAB in open heterogeneous scale-up.
- Management credibility 9/10 with consistent beats and no goalpost shifts.

BEAR CASE
- Trades 66x sales / 263x trailing P/E with top-5 customer concentration ~90%.
- Options flow bearish: $3.36M bearish premium vs $1.14M bullish (75% bearish).
- Insiders sold $159M in last 90 days (sentiment -40).
- Analyst target $245 implies 36% downside from $380.

OPTIONS POSITIONING
BEARISH_FLOW with 25% bullish premium ($1.14M calls vs $3.36M puts across 30 alerts, net $-2.22M directional). IV skew neutral (-1.34pp). Largest trades: $1.358M SOLD CALL $490 2026-08-21 SWEEP; $511k BOUGHT PUT $360 2026-07-17; $221k SOLD CALL $490 2026-08-21 SWEEP; $203k BOUGHT PUT $327.5 2026-07-02; $155k BOUGHT CALL $400 2026-07-17. Flow conflicts with today’s index-driven rally and suggests hedging or outright bearish bets into the rebalance.

X / SOCIAL CHATTER
Nasdaq-100 inclusion will force QQQ and other trackers to buy regardless of valuation. “Every ETF tracking the Nasdaq 100, including QQQ with $300B+ in assets now has to buy these stocks whether they want to or not.” (@1000xStocks)
Stock prices in flawless execution at 60x sales with heavy customer concentration; any AI capex pause would hurt disproportionately. “Overvalued! 60x sales.” (@athuinvests)
NVLink Fusion partnership highlighted at Computex but viewed as early-stage and already priced in.

MANAGEMENT CREDIBILITY
High credibility (9/10). Delivered beats in each of last four reported quarters (e.g., Q3 2024 guided $95-100M, actual $113M). Consistent execution, expanding margins, minimal excuses, and coherent “AI Infrastructure 2.0” narrative with no recurring one-time items or goalpost shifts.

SIGNAL CROSS-CHECK
Options flow and insider selling both bearish; technicals neutral; index-inclusion catalyst and strong fundamentals provide the only bullish offsets. Overall bearish signal dominance.

KEY CATALYSTS
Nasdaq-100 inclusion effective June 22; next earnings (likely late July).

KEY RISKS
66x sales valuation leaves little room for any AI capex slowdown; 90% top-5 customer concentration; beta 3.2 amplifies macro moves.

BOTTOM LINE
ALAB is ripping on mechanical index buying today, yet options and insiders are actively betting against further upside at already extreme multiples. The rebalance provides a short-term tailwind, but the risk/reward favors waiting for a post-inclusion digestion or better entry below $300.